The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.

Abstract

PURPOSE OF REVIEW Obesity is a major risk factor for metabolic syndrome-related comorbidities such as insulin resistance, type-II diabetes, and nonalcoholic fatty liver disease (NAFLD). A wealth of evidence indicates that the associated pathologies of the metabolic syndrome are aggravated by the presence of a chronic state of 'low-grade' inflammation in the… (More)
DOI: 10.1097/MCO.0b013e32834777fa

Topics

Cite this paper

@article{MartnezClemente2011The5P, title={The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.}, author={Marcos Mart{\'i}nez-Clemente and Joan Cl{\`a}ria and Esther Titos}, journal={Current opinion in clinical nutrition and metabolic care}, year={2011}, volume={14 4}, pages={347-53} }